Lenvatinib inhibits the growth of gastric cancer patient-derived xenografts generated from a heterogeneous population.
John D KaralisLynn Y YoonSuntrea T G HammerChangjin HongMin ZhuIbrahim NassourMichelle R JuShu XiaoEsther C Castro-DubonDeepak AgrawalJorge SuarezScott I ReznikJohn C MansourPatricio M PolancoAdam C YoppHerbert J ZehTae Hyun HwangHao ZhuMatthew R PorembkaSam C WangPublished in: Journal of translational medicine (2022)
Nude mice are a superior platform than NSG mice for generating PDXs from gastric cancer patients. Lenvatinib showed promising antitumor activity in PDXs established from a diverse Western patient population and warrants further investigation in gastric cancer.